Graph_RG: Dominating <scp>CASP16</scp> 's Small Molecule Affinity Prediction Subcategory—A Pose‐Free Framework for Billion‐Scale Virtual Screening

Protein-ligand interaction prediction is pivotal in early-stage drug development, enabling large-scale virtual screening, drug optimization, and reverse target searching. In this work, we present Graph_RG, our top-performing model in the CASP16 small molecule track's protein-ligand affinity prediction category, achieving a N-weighted Kendall's Tau of 0.42-significantly outperforming other submissions (second-best: 0.36). Beyond accuracy, Graph_RG is noncomplex dependent, hence exhibits exceptional computational efficiency, operating > 100 000× faster than conformation-search dependent prediction methods, thus enabling billion- to 10-billion-scale screening on standard servers. We further discuss the potential improvements for Graph_RG, including dataset optimization, atomic vector representation enhancements, and model architecture upgrades. We also introduce the potential broader applications in large-scale drug screening, reverse target identification, and GPCR-specific drug discovery. We also point out the development of an interactive web platform hosting Graph_RG and its derivative models to enhance accessibility. By integrating community feedback and iterative model refinement, this initiative bridges the gap between AI-driven predictions and practical drug discovery, fostering advancements in both computational methodologies and biomedical applications.